Clinical Laboratory Medical Technologist
Atlanta, GA
Revolution Healthcare Services
5x8 hrs, Days
Referral Bonus

Job Opportunity – Medical Laboratory Technologist (Hematology) – Georgia

Start Date: July 26, 2026

Location: Metropolitan Georgia

Compensation: Details provided to qualified applicants

Schedule: Day shift, 7:00 AM – 3:30 PM, with every other weekend rotation required. 13-week assignment.

Highlights:

• High-volume CORE laboratory environment supporting a large acute care facility with 600+ beds
• Extensive Hematology focus utilizing Sysmex analyzers and CellaVision technology
• Complex case mix including neonatal specimens and advanced differential interpretation
• Fast-paced laboratory requiring independent decision-making and technical proficiency
• Daily exposure to challenging specimens including turbid samples, platelet clumps, and abnormal cell morphology
• Opportunity to work with a specialized team in a critical care setting

Requirements:

• Active Medical Laboratory Technologist or Medical Technologist certification
• Extensive hands-on experience in Hematology within a CORE laboratory setting
• Demonstrated proficiency with Sysmex hematology analyzers and CellaVision systems
• Previous experience in a high-volume hospital laboratory (600+ beds preferred)
• Strong competency in performing and interpreting manual differentials, particularly neonatal specimens
• Proven ability to troubleshoot complex specimens and abnormal cell findings independently
• Must reside outside a 50-mile radius of the facility

Why It's a Great Opportunity:

This position offers an exceptional opportunity for an experienced hematology professional to make an immediate impact in a dynamic, high-acuity laboratory environment. You'll work with advanced instrumentation and handle a diverse range of challenging cases that will sharpen your technical expertise. Join a team that values precision, efficiency, and clinical excellence in supporting critical patient care across multiple service lines including neonatal and intensive care populations.